Clinical Trials Browser

Completed × Smoldering Multiple Myeloma × daratumumab × Clear all

NCT02316106 2025-04-27

A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma

Phase 2 Completed

Smoldering Multiple Myeloma, Multiple Myeloma